Gold nanoparticles functionalized with 3-mercapto-1-propansulfonate (AuNPs-3MPS) have been prepared and loaded with Methotrexate (MTX), an immunosuppressive agent used in the systemic treatment of moderate–severe inflammatory diseases. The effects of the AuNPs-3MPS@MTX topically administered in vitro on skin model and in vivo on imiquimod-induced psoriasis-like mice model, have been studied. Clinical response, epidermal thickness, cell proliferation rate and inflammation were tested. AuNPs-3MPS@MTX treated mice showed a decreasing of scaling and erythema score, reduction of epidermal thickness, parakeratosis and hyperkeratosis, compared to AuNPs-3MPS treated mice. Immunohistochemistry analysis staining displayed that Ki67, K6 CD3 and CD8 stainings were reduced in AuNPs-3MPS@MTX treated mice. Blood evaluation showed no differences in blood count and in ALT and AST levels before and after AuNPs-3MPS or AuNPs-3MPS@MTX treatment. Topical AuNPs-3MPS@MTX treatment is able to induce a reduction of keratinocytes hyperproliferation, epidermal thickness and also inflammatory infiltrate in vivo on imiquimod-induced psoriasis like mice model. © 2019
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model / Fratoddi, Ilaria; Benassi, Luisa; Botti, Elisabetta; Vaschieri, Cristina; Venditti, Iole; Bessar, Hagar; Samir, Maie A.; Azzoni, Paola; Magnoni, Cristina; Costanzo, Antonio; Casagrande, Viviana; Federici, Massimo; Bianchi, Luca; Pellacani, Giovanni. - In: NANOMEDICINE. - ISSN 1549-9634. - 17:(2019), pp. 276-286. [10.1016/j.nano.2019.01.006]
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model
Fratoddi, IlariaMembro del Collaboration Group
;Botti, Elisabetta
;Venditti, Iole;Magnoni, Cristina;Pellacani, Giovanni
2019
Abstract
Gold nanoparticles functionalized with 3-mercapto-1-propansulfonate (AuNPs-3MPS) have been prepared and loaded with Methotrexate (MTX), an immunosuppressive agent used in the systemic treatment of moderate–severe inflammatory diseases. The effects of the AuNPs-3MPS@MTX topically administered in vitro on skin model and in vivo on imiquimod-induced psoriasis-like mice model, have been studied. Clinical response, epidermal thickness, cell proliferation rate and inflammation were tested. AuNPs-3MPS@MTX treated mice showed a decreasing of scaling and erythema score, reduction of epidermal thickness, parakeratosis and hyperkeratosis, compared to AuNPs-3MPS treated mice. Immunohistochemistry analysis staining displayed that Ki67, K6 CD3 and CD8 stainings were reduced in AuNPs-3MPS@MTX treated mice. Blood evaluation showed no differences in blood count and in ALT and AST levels before and after AuNPs-3MPS or AuNPs-3MPS@MTX treatment. Topical AuNPs-3MPS@MTX treatment is able to induce a reduction of keratinocytes hyperproliferation, epidermal thickness and also inflammatory infiltrate in vivo on imiquimod-induced psoriasis like mice model. © 2019File | Dimensione | Formato | |
---|---|---|---|
Fratoddi_Effects_2019.pdf
solo gestori archivio
Note: https://www.sciencedirect.com/science/article/pii/S1549963419300188?via=ihub
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
642.06 kB
Formato
Adobe PDF
|
642.06 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.